EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Redefining injectable PMMA bone cement: Beta-tricalcium phosphate integration for bioactive and osteoconductive performance for minimally invasive applications

Chang-Chin Wu, Ling Yeh, Chih-Yung Chiang, Kai-Chiang Yang iD

Bio-Medical Materials and Engineering · 13.11.2026

DOI: 10.1177/09592989261487245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bio-Medical Materials and Engineering, online erschienen am 13.11.2026. Verfasst von Chang-Chin Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, En Chu Kong Hospital, New Taipei City, Taiwan. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, En Chu Kong Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Poly(methyl methacrylate) (PMMA) is commonly used as injectable bone cement; however, its exothermic polymerization, excessive stiffness, and bioinertness limit its clinical performance. To address these drawbacks, various types of PMMA-based bone cements modified with ceramic components have been developed.

Objective

We refined a PMMA-based bone cement with a high substitution of beta-tricalcium phosphate (β-TCP) for minimally invasive applications.

Methods

Composite cements with various weight ratios of β-TCP were in vitro characterized for the injectability, curing profile, radiopacity, weight change, compressive strength, and cytocompatibility. Osteoblast-like MG-63 cells were utilized for the biological assessments. For the in vivo evaluation, the composites were injected into the distal femora of rabbits, followed by micro-computed tomography (μ-CT) and histological analyses conducted after 24 weeks.

Results

Incorporation of β-TCP significantly lowered the maximum curing temperature and extended the setting time, while good injectability was still maintained. As the β-TCP content increased, both radiopacity and compressive strength increased proportionally with minor weight changes after immersion in simulated body fluid. Cytocompatibility assays demonstrated a reduction in lactate dehydrogenase release with β-TCP substitution, accompanied by improved cell viability. In vivo studies using μ-CT and histology demonstrated improved bone-cement adaptation, direct contact with host bone, and deposition of new bone matrix without the formation of fibrous tissue. Conclusion: β-TCP substitution enhanced the handling, radiological, mechanical, and biological properties of PMMA cement, enabling partial osteointegration at the bone-cement interface. The findings suggest that this injectable PMMA/β-TCP composite can be delivered through a biopsy needle and holds promise for minimally invasive applications such as vertebroplasty, kyphoplasty, and defect filling.

Schlagwörter

Stichwörter der Autor:innen

bone void fillerinjectable bone cementpoly(methyl methacrylate)radiopacitytricalcium phosphate

Autor:innen und Institutionen

  • Department of Orthopedics, En Chu Kong Hospital, New Taipei City, Taiwan.
  • School of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
  • Orthopedics Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
  • Department of Pediatric Dentistry, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia.

ORCID-Profile: Kai-Chiang Yang

Förderung

  • Ministry of Science and Technology, Taiwan
  • En Chu Kong Hospital

Zitieren

APA

Wu, C. C., Yeh, L., Chiang, C. Y., & Yang, K. C. (2026). Redefining injectable PMMA bone cement: Beta-tricalcium phosphate integration for bioactive and osteoconductive performance for minimally invasive applications. Bio-Medical Materials and Engineering. https://doi.org/10.1177/09592989261487245

Vancouver

Wu CC, Yeh L, Chiang CY, Yang KC. Redefining injectable PMMA bone cement: Beta-tricalcium phosphate integration for bioactive and osteoconductive performance for minimally invasive applications. Bio-Medical Materials and Engineering. 2026. doi:10.1177/09592989261487245

BibTeX
@article{Wu2026,
  author = {Wu, Chang-Chin and Yeh, Ling and Chiang, Chih-Yung and Yang, Kai-Chiang},
  title = {Redefining injectable PMMA bone cement: Beta-tricalcium phosphate integration for bioactive and osteoconductive performance for minimally invasive applications},
  journal = {Bio-Medical Materials and Engineering},
  year = {2026},
  doi = {10.1177/09592989261487245}
}
Kostenlos starten →